scispace - formally typeset
X

Xiuxiu Cong

Researcher at Jilin University

Publications -  13
Citations -  169

Xiuxiu Cong is an academic researcher from Jilin University. The author has contributed to research in topics: Medicine & Immune system. The author has an hindex of 5, co-authored 5 publications receiving 67 citations.

Papers
More filters
Journal ArticleDOI

Photodynamic therapy produces enhanced efficacy of antitumor immunotherapy by simultaneously inducing intratumoral release of sorafenib.

TL;DR: A rapidly released sorafenib acts synergistically with the low-dose PDT to inhibit tumor growth by inducing strong T cell-dependent local and systemic antitumor immune responses, reprograming the tumor immune microenvironment, and limiting the interaction between cytotoxic CD8+ T cells and immunosuppressive cells.
Journal ArticleDOI

Intratumoral delivery of CCL25 enhances immunotherapy against triple-negative breast cancer by recruiting CCR9+ T cells

TL;DR: It is found that CCL25, the only chemokine for CCR9+ cells, is not expressed in human or murine triple-negative breast cancers (TNBCs), raising a hypothesis that intratumoral delivery of CCL 25 may enhance antitumor immunotherapy in TNBCs.
Journal ArticleDOI

Cationic Liposome/DNA Complexes Mediate Antitumor Immunotherapy by Promoting Immunogenic Tumor Cell Death and Dendritic Cell Activation

TL;DR: Both the local tumor growth and the distant tumor formation were significantly inhibited by T cell-dependent antitumor immune responses after intratumoral injection of CLN/DNA.
Journal ArticleDOI

Intratumoral delivery of M-CSF by calcium crosslinked polymer micelles enhances cancer immunotherapy

TL;DR: A tumor acidity-responsive biomacromolecule delivery system was designed to intratumorally deliver an immune-activating cytokine, macrophage colony-stimulating factor (M-CSF) and attenuate the acidic microenvironment and inhibited tumor growth.
Journal ArticleDOI

An optimized ionizable cationic lipid for brain tumor-targeted siRNA delivery and glioblastoma immunotherapy.

TL;DR: In this article , a new cationic lipid nanoparticle (LNP) that can efficiently deliver siRNA across the blood-brain barrier (BBB) and target mouse brain is prepared for modulating the tumor microenvironment for GBM immunotherapy.